Compounded semaglutide is a clinically formulated medication as a GLP-1 receptor agonist medication that can be compounded by licensed pharmacies. GLP-1 receptor agonists are designed to interact with GLP-1 receptors, which are naturally found throughout the body and are involved in various physiological processes including glucose metabolism and gastrointestinal function. Compounded semaglutide has not been approved by the FDA and is not equivalent to any FDA-approved products. Your healthcare provider can explain how GLP-1 receptors function in the body, discuss the intended mechanism of semaglutide, and determine whether it may be appropriate for your individual treatment plan as part of a comprehensive approach to health management. This medication should always be used under medical supervision, taking into account personal health factors and possible side effects.
Clinical professionals typically follow a dosing schedule that resembles the following:
Month 1 (weeks 1-4): 0.25mg
Month 2 (weeks 5-8): 0.50mg
Month 3 (weeks 9-12): 1mg
Month 4 (weeks 13-16): 1.7mg
Month 5+ (weeks 17+): 2.4mg
Many patients decide to maintain on a weekly dose below the maximum dose through their course of therapy.
This is not medical advice. The dosages provided are for informational purposes only and do not replace professional medical guidance. Each patient is unique, and physicians determine prescriptions based on individual medical needs. Always consult your physician to determine the appropriate titration schedule and medication.
Coby Health believes in flexibility and transparency. Our pricing structure is designed to ensure there are no hidden fees or surprises in your costs.
Compounded semaglutide is not reviewed or approved by the FDA for safety or effectiveness. Compounded semaglutide is not a generic form of Ozempic® and Wegovy®. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby Health has no affiliation with Novo Nordisk. See Important Safety Information.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk. See Important Safety Information.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk. See Important Safety Information.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk. See Important Safety Information.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk. See Important Safety Information.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk.
Product images are for illustration only. Actual product will vary. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby has no affiliation with Novo Nordisk. See Important Safety Information.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Our online visit will guide you through the process to connect with a doctor.
Upon approval, your clinician will provide a personalized treatment plan.
Your GLP-1 weight loss medication will be delivered to your doorstep.
GLP-1 receptor agonist medications are formulated to target GLP-1 receptors in your body. With no-wait consultations and free shipping upon approval, Coby Health members have the most straightforward experience possible.
At Coby Health, the initial dose for compounded semaglutide generally starts at 0.25mg per week, subject to approval by your medical provider.
Your provider will gradually increase your compounded semaglutide dose to provide the best results and minimize side effects.
At Coby Health, we strive to provide transparent pricing to make compounded semaglutide both affordable and predictable.
Dual GLP-1/GIP receptor agonist medication
Choose from monthly (cancel anytime) and quarterly packages
Includes at-home injection kit (alcohol pads and syringes)
Product images are for illustration only. Actual product will vary. Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness. Compounded tirzepatide is not a generic form of Mounjaro® and Zepbound®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
